These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2166676)

  • 1. Long-term verapamil treatment increases [3H]imipramine binding in human platelets.
    Cohen A; Weizman A; Eldar M; Rehavi M
    Eur J Pharmacol; 1990 Jun; 181(3):311-4. PubMed ID: 2166676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
    Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
    Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between 3H-imipramine binding, 14C-serotonin uptake, and the surface area of blood platelets.
    Demet EM; Chicz-Demet A; Shaffer E; Ocariz J
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):289-96. PubMed ID: 2163060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.
    Friedl W; Propping P; Weck B
    Psychopharmacology (Berl); 1983; 80(1):96-9. PubMed ID: 6306712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
    Egrise D; Desmedt D; Schoutens A; Mendlewicz J
    Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine binding sites in brain and platelets: role in affective disorders.
    Hrdina PD
    Int J Clin Pharmacol Res; 1989; 9(2):119-22. PubMed ID: 2541089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personality features and platelet 3H-imipramine binding.
    Castrogiovanni P; Maremmani I; Di Muro A; Rotondo A; Marazziti D
    Neuropsychobiology; 1992; 25(1):11-3. PubMed ID: 1318512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
    Phillips OM; Wood KM; Williams DC
    J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased platelet 3H-imipramine binding sites in classical migraine.
    Geaney DP; Rutterford MG; Elliott JM; Schächter M; Peet KM; Grahame-Smith DG
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):720-3. PubMed ID: 6086845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of serotonin system in bulimia.
    Marazziti D; Macchi E; Rotondo A; Placidi GF; Cassano GB
    Life Sci; 1988; 43(25):2123-6. PubMed ID: 2850422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human plasma inhibitors of platelet serotonin uptake and imipramine receptor binding: extraction and heterogeneity.
    Brusov OS; Fomenko AM; Katasonov AB
    Biol Psychiatry; 1985 Mar; 20(3):235-44. PubMed ID: 2983787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization and partial purification of the high affinity [3H] imipramine binding site from human platelets.
    Rehavi M; Skolnick P; Paul SM
    FEBS Lett; 1982 Dec; 150(2):514-8. PubMed ID: 6297983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.